GENE ONLINE|News &
Opinion
Blog

Hepatocellular Carcinoma
Trials & Approvals
AstraZeneca’s Imfinzi, Tremelimumab Combo Significantly Improves Overall Survival in Phase 3 Trials
2021-10-18
Trials & Approvals HOPE-B Trial
uniQure’s Inquiry Shows Hemophilia B Gene Therapy not Likely to Have Induced Liver Cancer
2021-03-30
Technology CRISPR
CRISPR-Based Screening Implicates Mitochondrial Phosphatase Gene in Hypoxic Survival of Liver Cancer Cells
2021-02-03
Trials & Approvals
uniQure’s Hemophilia B Gene Therapy Put on Clinical Hold by the FDA
2020-12-22
Liver Cancer
China’s Regulatory Body Accepts Application for First Selective Internal Radiation Therapy for HCC
2020-11-29
R&D Liver Disease
Roche’s Elecsys GALAD Score that Predicts HCC Occurrence, Bags Breakthrough Designation
2020-03-06
Cancer
ESMO Asia 2019 Roundup
2019-12-10
Trials & Approvals Hepatocellular Carcinoma
New hepatocellular carcinoma approval for Pembrolizumab – KN-224
2018-11-14
Trials & Approvals
Singapore HSA approves phase I/II clinical trial for precision T-cell receptor immunotherapy
2018-09-14
Today In History HBV Integration
November 8, 2012: Completion of the Liver Cancer Genome
2017-11-07
LATEST
Core8 Group and MedArmor to Pioneer Vietnam’s First AI x ESG Hospital
2024-12-10
The Future of Generative AI for New Drug Development and Precision Medicine
2024-12-09
How FIRM is Shaping Regenerative Medicine in Japan
2024-12-09
AI, Smart Tech, and ICT to Unite the Global Biotech and Healthcare Industries in 2025
2024-12-06
Core8 Group to Establish Vietnam’s First Comprehensive Biotechnology Incubator
2024-12-05
Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area
2024-12-05
Ipsen Bets $600M on Biomunex’s First-in-Class T-Cell Engager BMX-502
2024-12-03
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top